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Abstract
Spatially restricting cAMP production to discrete subcellular locations permits selective regulation of specific functional
responses. But exactly where and how cAMP signaling is confined is not fully understood. Different receptors and adenylyl
cyclase isoforms responsible for cAMP production are not uniformly distributed between lipid raft and non-lipid raft
domains of the plasma membrane. We sought to determine the role that these membrane domains play in organizing
cAMP responses in HEK293 cells. The freely diffusible FRET-based biosensor Epac2-camps was used to measure global cAMP
responses, while versions of the probe targeted to lipid raft (Epac2-MyrPalm) and non-raft (Epac2-CAAX) domains were used
to monitor local cAMP production near the plasma membrane. Disruption of lipid rafts by cholesterol depletion selectively
altered cAMP responses produced by raft-associated receptors. The results indicate that receptors associated with lipid raft
as well as non-lipid raft domains can contribute to global cAMP responses. In addition, basal cAMP activity was found to be
significantly higher in non-raft domains. This was supported by the fact that pharmacologic inhibition of adenylyl cyclase
activity reduced basal cAMP activity detected by Epac2-CAAX but not Epac2-MyrPalm or Epac2-camps. Responses detected
by Epac2-CAAX were also more sensitive to direct stimulation of adenylyl cyclase activity, but less sensitive to inhibition of
phosphodiesterase activity. Quantitative modeling was used to demonstrate that differences in adenylyl cyclase and
phosphodiesterase activities are necessary but not sufficient to explain compartmentation of cAMP associated with
different microdomains of the plasma membrane.
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Introduction
Many different G protein coupled receptors (GPCRs) are
capable of stimulating cAMP production. Furthermore, this
ubiquitous second messenger can regulate a variety of cellular
activities. Yet despite the fact that multiple receptors can stimulate
cAMP production in any given cell, they do not always produce
identical functional responses. Such observations led to the
original hypothesis that that receptor activation does not
necessarily produce a uniform increase in cAMP throughout the
cell [1,2]. Localized increases in cAMP allow for targeted
regulation of cAMP-dependent responses in distinct subcellular
compartments.
Early studies investigating compartmentalized cAMP signaling
focused on differences in second messenger production associated
with membrane and non-membrane fractions of cells [1–4]. This
was due to technical limitations that only allowed cAMP
measurements in particulate (membrane) or supernatant (cytosolic)
fractions of cell or tissue homogenates. More recently the
development of various biosensors has made it possible to measure
changes in cAMP activity in intact living cells [5–7]. However,
most studies have still focused on differences between cAMP
activity near the plasma membrane and the bulk cytoplasmic
compartment [8–12]. The results suggest that receptor activation
produces differences in the magnitude and the time course of
cAMP responses observed in these two compartments. However,
the assumption has often been that cAMP signaling near the
plasma membrane is uniform.
A number of factors may actually contribute to non-uniformity
of cAMP signaling in different subcellular compartments. Local-
ized differences in cAMP metabolism by phosphodiesterases
(PDEs) are often cited [9,10,12–15]. However, inhomogeneities
in the distribution of receptors and other signaling proteins
responsible for cAMP production are also believed to play a key
role [16,17]. Even though many of these proteins are associated
with the plasma membrane, there is clear evidence not all are
distributed homogenously. Many are either included or excluded
from lipid rafts, which are detergent-resistant membrane domains
rich in cholesterol. These regions of the membrane, which in some
cells include caveolae, provide a platform for the aggregation of
various signaling proteins through lipid-protein and protein-
protein interactions [18–21].
Examples of receptors that exhibit non-uniform distribution
between lipid raft and non-lipid raft domains of the plasma
membrane include b-adrenergic receptors (bARs) and E type
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prostaglandin receptors (EPRs). Both are capable of stimulating
cAMP production, yet bARs are often associated with the
cholesterol-rich, buoyant fractions of the plasma membrane, as
identified by sucrose density centrifugation, while EPRs are only
found in non-raft fractions [8,16,22–27]. Likewise, there are also
differences in the distribution of various isoforms of adenylyl
cyclase, the enzyme responsible for synthesis of cAMP, between
raft and non-raft membrane fractions [16,17,26–28]. These
observations raise the possibility that cAMP production near the
plasma membrane is not uniform. The purpose of this study was to
test this hypothesis using FRET-based biosensors targeted to lipid
raft and non-lipid raft microdomains of the plasma membrane.
The results demonstrate that cAMP signaling associated with the
plasma membrane is not homogeneous and that there are
differences between raft and non-raft domains that are due to
variations in the distribution of receptors as well as adenylyl
cyclase activity.
Results
Membrane Microdomain Targeting of FRET-based
Biosensors
Epac2-camps is a freely diffusible FRET-based biosensor that
responds to changes in cAMP occurring throughout the cytosolic
compartment of cells [29,30]. Epac2-CAAX was targeted to non-
lipid raft domains of the plasma membrane, while Epac2-
MyrPalm was targeted to lipid rafts. Previous studies have
demonstrated that the targeting sequences used here direct
expression to these specific membrane domains [31–34]. Confocal
imaging confirmed that Epac2-camps is expressed throughout the
cytoplasm, while Epac2-CAAX and Epac2-MyrPalm are concen-
trated at the plasma membrane (figure 1). However, lipid raft and
non-lipid raft membrane domains cannot be resolved using
conventional microscopy techniques [35,36]. Therefore, to verify
that Epac2-MyrPalm was being targeted to lipid rafts, while
Epac2-CAAX was not, we measured the mobility of each using
FRAP in control cells and cells in which lipid rafts had been
disrupted by depleting membrane cholesterol with methyl-b-
cyclodextrin (MBCD). Disrupting lipid rafts in this manner is
expected to have a greater effect on the mobility of proteins
associated specifically with lipid rafts.
The results demonstrate that cholesterol depletion did not
significantly affect the mobility of Epac2-CAAX (figures 1C, 1E,
and 1F). In control cells, the fluorescence recovery half time (t1/2)
and mobile fraction (Mf) were 8.161.6 s and 0.8860.040 (n = 14),
respectively. The corresponding values in MBCD-treated cells
were 9.061.9 s and 0.9160.030 (n = 10), respectively. In contrast,
cholesterol depletion did significantly alter the mobility of Epac2-
MyrPalm (figure 1D, 1E, and 1F). In control cells the t1/2 and
Mf were 1561.6 s and 0.8460.050 (n= 5), respectively, while in
MBCD-treated cells the t1/2 increased to 3364.4 s and the Mf
decreased to 0.6260.030 (n= 8). The decrease in mobility is
consistent with the effect that cholesterol depletion has been shown
to have on raft associated proteins in other studies [37–41]. These
results support the idea that Epac2-MyrPalm was targeted to lipid
raft domains, while Epac2-CAAX was not.
Receptor-dependent cAMP Production in Different
Membrane Domains
Having obtained evidence that the two membrane bound
probes are targeted to different microdomains in the plasma
membrane, we then looked at the cAMP responses occurring in
these locations and compared them to the response observed
throughout the entire cytoplasmic compartment using Epac2-
camps. We started by measuring responses to endogenous bAR
and EPR stimulation. In HEK293 cells, like many other cell types,
bARs have been shown to be enriched in lipid raft domains while
EPRs are excluded from those membrane fractions [8].
All three probes responded when cells were exposed to the bAR
agonist isoproterenol (Iso) (figure 2). The FRET responses (DR/
R0) of Epac2-camps (2061.1%, n= 8) and Epac2-MyrPalm
(1760.72%, n= 9) were similar in magnitude. However, the size
of the response detected by the Epac2-CAAX probe (1260.58%,
n= 5) in non-lipid raft domains was significantly smaller
(figure 2D). Previous studies have suggested that differences in
the size of cAMP responses detected using targeted biosensors
similar to the ones used in the present study can be attributed to
differences in subcellular PDE activity [9]. However, addition of
the non-specific PDE inhibitor 3-isobutyl-1-methylxanthine
(IBMX) did not alter the magnitude of the maximal Iso response
detected by any of the probes.
Another possible explanation for the smaller size of the response
detected by Epac2-CAAX is that there are fewer bARs found in
non-lipid raft regions of the plasma membrane [8]. To evaluate
this possibility, we next examined the responses to activation of
EPRs, using prostaglandin E1 (PGE1) as an agonist (figure 3).
Because EPRs are absent from lipid-raft domains, we predicted
that the pattern of responses detected in different subcellular
locations might differ from that observed following bAR activa-
tion. However, this was not the case. The magnitude of the
maximal FRET response produced by PGE1 was not significantly
different from that produced by Iso. Following exposure to a
maximally stimulating concentration of PGE1, the FRET
responses produced by Epac2-camps (2160.97%, n= 23) and
Epac2-MyrPalm (1761.3, n = 15) were significantly larger than
the response produced by Epac2-CAAX (1261.0, n = 20)
(figure 3D). Again, this difference could not be attributed to
PDE activity, since addition of IBMX had no effect on the
magnitude of the response produced by any of the probes. These
results indicate that maximal activation of both b-adrenergic and
E-type prostaglandin receptors produces cAMP responses that
saturate all three probes.
The lack of any obvious difference between responses produced
by Iso and PGE1 might be explained if the receptors involved
are not actually associated with different microdomains in the
plasma membrane. To evaluate this possibility, we examined the
responses produced by Iso and PGE1 in cells pretreated with
MBCD. Cholesterol depletion has been shown to disrupt lipid rafts
and selectively alter responses to receptors found in those
membrane domains [42]. In MBCD-treated cells, we found that
the magnitude of the responses produced by bAR stimulation were
smaller in all three subcellular locations (figure 4). This was
demonstrated by normalizing the size of the FRET response
produced by a maximally stimulating concentration of Iso to that
observed following maximal activation of the probe by exposure to
Iso plus IBMX. In control cells, the size of the FRET response
observed in the presence of Iso plus IBMX was the same as the size
of the response to Iso alone (see figure 2). However, in MBCD-
treated cells, addition of IBMX resulted in a significant increase in
the size of the FRET response produced by maximal bAR
stimulation alone. This indicates that the sensitivity of the cAMP
response to bAR stimulation had been reduced. However, the size
of the normalized FRET responses of Epac2-camps (4163.8% of
max; n= 6) and Epac2-MyrPalm (3662.6% of max; n= 10) were
significantly smaller than the FRET response of Epac2-CAAX
(7066.5% of max; n = 8) in non-lipid raft domains (figure 4D).
The change in the relative size of the response to Iso was not due a
change in the size of the responses to Iso plus IBMX, since they
Membrane Microdomains and cAMP Compartmentation
PLOS ONE | www.plosone.org 2 April 2014 | Volume 9 | Issue 4 | e95835
were the same as in control cells. The fact that cholesterol
depletion affected the Epac2-camps response supports the idea
that bARs found in lipid raft domains contribute to global cAMP
responses. The observation that there was an Epac2-CAAX
response that was significantly less sensitive to cholesterol depletion
suggests that there are at least some bARs associated with non-
lipid raft regions of the plasma membrane.
Unlike the effects it had on bAR mediated responses, cholesterol
depletion had no detectible effect on the responses to EPR
activation (figures 4E–H). Just as in control cells, PGE1 elicited
FRET responses from all three probes that were not significantly
different from the maximal response observed following addition
of IBMX: Epac2-camps, 9266.5% of max (n= 4); Epac2-
MyrPalm, 11063.0% of max (n= 4); and Epac2-CAAX,
9469.4% of max (n = 4). This is consistent with the idea that
cAMP produced by exposure to PGE1 is due to activation of EPRs
found in non-lipid raft fractions of the plasma membrane.
Basal cAMP Levels in Different Membrane Domains
The results described above support the idea that the
membrane domain in which bARs are found can determine
whether or not they produce local or global cAMP responses in
HEK293 cells. However, this does not explain why the response of
Epac2-CAAX, which is associated with non-lipid raft regions of
the plasma membrane, is significantly smaller than the responses
associated with either the bulk cytoplasmic domain or lipid raft
domains in control cells (see figures 2 and 3). An alternative
explanation is that basal levels of cAMP vary in different
subcellular locations within the cell. It is often assumed that basal
levels of cAMP throughout the cell are below the threshold for
Figure 1. FRET-based biosensors targeted to different membrane microdomains. A, structure of individual Epac2-based biosensor
constructs. B, Confocal images of HEK293 cells expressing Epac2-camps (Epac2), Epac2-CAAX (CAAX), and Epac2-MyrPalm (MyrPalm). C and D, effect
of cholesterol depletion on the time course of fluorescence recovery after photobleaching in HEK293 cells expressing Epac2-CAAX or Epac2-MyrPalm.
E and F, summary of fluorescence recovery half-time (t1/2) and mobile fraction (Mf) in control and MBCD-treated cells. Differences between control
(n = 14) and MBCD-treated (n = 10) cells expressing Epac2-CAAX were not significant (t1/2, p = 0.378; Mf, p = 0.517). Differences between control (n = 5)
and MBCD-treated (n = 8) cells expressing Epac2-MyrPalm were significant (t1/2, p = 0.002; Mf, p = 0.003).
doi:10.1371/journal.pone.0095835.g001
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detection by biosensors. But what if basal cAMP levels in
cytoplasmic regions associated with non-lipid rafts are actually
high enough to partially activate the Epac2-CAAX sensor?
Subsequent stimulation of cAMP production would elicit a
maximal FRET response (due to saturation of the biosensor) that
appears smaller than cAMP responses in other microdomains.
The idea that basal cAMP concentrations vary in different
subcellular compartments has been demonstrated in other cells
types [28,30]. To determine if this might also be the case in
HEK293 cells, we used the AC inhibitor MDL12330A (MDL)
[43]. Upon exposure to 100 mM MDL, there was no obvious
change in the FRET response of Epac2-camps (20.2660.45;
n = 9) and Epac2-MyrPalm (20.7860.43; n= 8). However, MDL
did produce a significant decrease in the FRET response of Epac2-
CAAX (25.860.45; n= 15) that was reversible upon washout
(figures 5A–D), suggesting that basal cAMP levels are signifi-
cantly higher in non-lipid raft regions of the cell. To rule out the
possibility that MDL might be affecting the Epac2-CAAX probe
in a non-specific manner, we also treated cells expressing the
different biosensors with MDL after first stimulating cAMP
production with Iso. Under these conditions, exposure to MDL
inhibited the FRET response of all three biosensors (figures 5E–
H). These data indicate that the effects of MDL are due to
inhibition of AC activity, supporting the idea that basal levels of
cAMP associated with non-lipid raft regions of the plasma
membrane are indeed higher than subcellular regions associated
with lipid rafts and the bulk cytoplasmic domain.
Comparing the difference between the minimum response
observed following exposure to 100 mM MDL and the maximum
response observed following exposure to Iso plus IBMX, the
dynamic range of all three probes turns out to be very similar:
Epac2-camps, 2061.1%; Epac2-MyrPalm, 1760.7%; and Epac2-
CAAX, 1761.0%. The fact that MDL did not affect the baseline
response of Epac2-camps and Epac2-MyrPalm, indicates that the
basal levels of cAMP found where these probes are expressed is
below their activation threshold (#10 nM). Using equation 1(see
Materials and Methods), the basal concentration of cAMP detected by
Epac2-CAAX was estimated to be 93621 nM (n= 24), or at least
10 fold higher.
Higher basal levels of cAMP can be explained if cAMP
production is elevated and/or cAMP hydrolysis is reduced. The
fact that MDL inhibited the baseline response of Epac2-CAAX
indicates that there is significant basal AC activity stimulating
cAMP production associated with non-lipid raft domains of these
cells. To determine whether this basal AC activity is higher than it
is in other regions of the cell, we examined the sensitivity of the
response of the different probes to forskolin, an agonist that
directly activates AC independent of receptor activation (figure 6).
The prediction is that submaximally stimulating concentrations of
forskolin should produce a greater cAMP response in regions
where there is a greater amount of basal AC activity. Consistent
Figure 2. Effect of the b-adrenergic receptor (bAR) agonist isoproterenol (Iso) on cAMP responses detected by biosensors targeted
to different microdomains. A-C, time course of changes in the FRET response (DR/R0) and corresponding pseudocolor images obtained from cells
expressing Epac2-camps (Epac2), Epac2-CAAX (CAAX), and Epac2-MyrPalm (MyrPalm), under control conditions (a), and following exposure to 30 nM
Iso (b) and 30 nM Iso+100 mM IBMX (c). D, comparison of average FRET responses to maximal bAR stimulation (30 nM Iso) and maximal cAMP
production (Iso+100 mM IBMX). (n = 5–9; *p,0.001) E, concentration-response curves for Iso activation of FRET response in cells expressing different
biosensors (n = 3–11). Concentrations of Iso producing half maximal activation (EC50) of Epac2-camps (4.361.0 nM), Epac2-CAAX (2.560.37 nM), and
Epac2-MyrPalm (2.460.20 nM) were not significantly different (p.0.05).
doi:10.1371/journal.pone.0095835.g002
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with this idea, the Epac2-CAAX FRET response produced by
1 mM forskolin was 9564.6% (n= 11) of the maximum response
observed following subsequent exposure to 10 mM forskolin. This
was significantly larger than the magnitude of the normalized
FRET response produced by Epac2-camps (2365.1% of max,
n = 7) or Epac2-MyrPalm (4762.7% of maximum, n= 12). These
results indicate that the higher basal level of cAMP associated with
non-lipid raft domains of the cell is due at least in part to a greater
amount of basal AC activity.
A reduction in cAMP metabolism due to lower PDE activity
could also contribute to higher basal levels of cAMP. If this is true,
then one would expect cAMP responses in those subcellular
locations to be less sensitive to PDE inhibition. Although multiple
PDE isoforms are capable of metabolizing cAMP, PDE3 and
PDE4 are the predominant subtypes in HEK293 cells [44,45]. We
tested the role of each of these PDE isoforms using subtype-
selective inhibitors. Exposure to either cilostamide alone (10 mM),
a selective PDE3 inhibitor [46], or rolipram alone (10 mM), a
selective PDE4 inhibitor [47], did not produce a detectable change
in FRET responses by any of the probes (data not shown),
suggesting that differences in PDE activity may not contribute
significantly to differences in basal cAMP activity. To evaluate the
potential role of differences in PDE activity further, we examined
the effect of these inhibitors in the presence of a submaximally
stimulating concentration of Iso (3 nM). Under these conditions,
inhibition of either PDE3 or PDE4 produced cAMP responses that
could be detected by all three probes (figure 7). Although there
was some variability, when normalized to the magnitude of the
response produced by 3 nM Iso alone, the effect that inhibition of
PDE3 had on the responses detected by Epac2-camps (43613%;
n=9), Epac2-CAAX (2365.0%; n= 13), and Epac2-MyrPalm
(2264.1%; n= 8) were not statistically different (figure 7A).
However, inhibition of PDE4 did have a more significant effect on
the normalized responses detected by Epac2-camps (5566.1%;
n= 8) and Epac2-MyrPalm (66615%; n= 5) than it did on the
response of Epac2-CAAX (3265.3%; n= 11) (figure 7D).
Modeling Compartmentalized cAMP Responses
We further investigated the mechanisms responsible for cAMP
compartmentation in HEK293 cells using a computational
approach, by constructing a single cell model of cAMP signaling
that consists of lipid raft and non-lipid raft sub-plasma membrane
domains and a bulk cytosolic domain. The total cell volume was
assumed to be 2.5 pL [11], with 5% of that attributed to the
membrane associated compartments. Rich et al. [10,11] previ-
ously described cAMP signaling in HEK293 cells using a two
compartment (membrane and cytosol) model, where the mem-
brane compartment volume was calculated as 1.5 to 2% of a
spherically shaped cell. However, the morphology of HEK cells is
flat, in which case a membrane compartment of similar thickness
would make up a larger proportion of the total cell volume. Lipid
rafts made up 30% of the total membrane compartment volume.
Figure 3. Effect of the E type-prostaglandin receptor (EPR) agonist PGE1 on cAMP responses detected by biosensors targeted to
different microdomains. A–C, time course of changes in FRET response (DR/R0) and corresponding pseudocolor images from cells expressing
Epac2-camps (Epac2), Epac2-CAAX (CAAX), and Epac2-MyrPalm (MyrPalm), under control conditions (a), and following exposure to 1 mM PGE1 (b) and
1 mM PGE1+100 mM IBMX (c). D, comparison of average FRET responses to maximal EPR stimulation (1 mM PGE1) and maximal cAMP production
(PGE1+100 mM IBMX). (n = 4; *p,0.001) E, concentration-response curves for PGE1 activation of FRET response in cells expressing the different
biosensors (n = 4–11). Concentrations of PGE1 producing half maximal activation (EC50) of Epac2-camps (2061.7 nM), Epac2-CAAX (2566.0 nM), and
Epac2-MyrPalm (2861.4 nM) were not significantly different (p.0.05).
doi:10.1371/journal.pone.0095835.g003
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Assuming both membrane compartments have similar surface to
volume ratios, lipid rafts would then comprise 30% of the cell
surface area, which is consistent with experimental estimates of 13
to 50% [20].
Initial values for the other model parameters were based on
experimental data as described in table 1. These parameters were
then optimized simultaneously to several of our experimental
findings. This included the estimated basal cAMP levels in the
three microdomains (figure 8A), as well as the effect of receptor
independent stimulation of AC activity (figure 8B) and inhibition
of PDE3 (figure 8C) and PDE4 (figure 8D) activity. Basal AC
activity was assumed to be ,4% of the maximal receptor
stimulated value previously used by Rich et al. [10]. This is in
line with the basal rate of production estimated from experimental
studies [48]. The maximal rate of cAMP hydrolysis by PDEs was
significantly less than the values used in earlier models [10,14], but
much closer to estimates calculated from previously published
experimental data [44]. Consistent with the findings of Lynch et
al. [44], the model was constrained by assuming that the majority
of cAMP hydrolysis was due to PDE4 activity, while PDE3 activity
accounted for the remainder. Furthermore, in keeping with the
experimental results of Matthiesen and Nielson [45], PDE3
activity was included only in the membrane compartments, while
the majority of the PDE4 activity was confined to the bulk
cytoplasmic compartment. However, with these constraints on the
activity and/or distribution of AC and PDE activity, it was also
necessary to assume that the movement of cAMP between
compartments was restricted. Using cAMP flux rates between
the membrane compartments and the bulk cytoplasmic compart-
ment that are in line with those previously described by Rich et al.
[10,11], the model was able to approximate key experimental
findings of the present study (figure 8).
Discussion
Comparison to Previous Work
A variety of biosensors have been used to demonstrate that
cAMP signaling is compartmentalized in intact, living cells.
However, most studies have focused on the differences between
cAMP responses occurring near the plasma membrane and the
rest of the cytosolic compartment [8–11,49]. The implied
assumption is often that cAMP signaling near the plasma
membrane is uniform. However, given the heterogeneous nature
of the cell membrane, this seems unlikely. For example, Wachten
et al. [28] demonstrated that receptor activation can produce
compartmentalized cAMP responses in GH3B6 pituitary cells that
are created by different AC isoforms found in lipid raft domains of
the plasma membrane. In the present study, we tested the
Figure 4. Effect of cholesterol depletion on the sensitivity of receptor-dependent cAMP responses detected by biosensors targeted
to different microdomains. A–C, time course of changes in normalized FRET response (DR/R0) in cells expressing Epac2-camps (Epac2), Epac2-
CAAX (CAAX), and Epac2-MyrPalm (MyrPalm) following exposure to a maximally stimulating concentration of the bAR agonist isoproterenol (Iso).
Responses are normalized to the magnitude of the maximal FRET response produced by Iso plus IBMX. D, comparison of average changes in
normalized FRET responses to 30 nM Iso (n = 6–10, *p,0.001). E–G, time course of changes in normalized FRET response to a maximally stimulating
concentration of the EPR agonist PGE1. Responses are normalized to the magnitude of the maximal FRET response produced by exposure to PGE1
plus IBMX. H, comparison of average changes in normalized FRET responses to 1 mM PGE1 (n = 4; ns = not significant).
doi:10.1371/journal.pone.0095835.g004
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hypothesis that compartmentation of cAMP signaling may be a
consequence of segregation of signaling proteins between lipid raft
and non-lipid raft membrane domains.
In the present study, we used FRAP experiments to demonstrate
that our Epac2-based probes were expressed in different mem-
brane domains. Following the disruption of lipid rafts by
cholesterol depletion, the mobility of only the raft-associated
Epac2-MyrPalm probe was significantly reduced (figure 1).
Similar treatment had little effect on the mobility of Epac2-
CAAX, the biosensor that is presumably excluded from lipid rafts.
The mechanism for reduced mobility of lipid raft-associated
proteins is still unclear. Some studies have reported that the
reduction in the mobility of raft-associated protein following
cholesterol depletion is due to the changes in their interaction with
actin cytoskeleton [50,51]. This conclusion was supported by the
experiments in which raft-associated proteins exhibited higher
mobility following actin cytoskeleton disruption [51]. Other studies
have suggested that the presence of cholesterol can locally fluidize
the otherwise rigid sphingolipid-rich regions of the membrane
[52,53]. Consistent with this mechanism, several studies have
demonstrated that cholesterol depletion preferentially reduces the
mobility of raft-associated proteins [39,54,55].
The idea that the targeting sequences we used are directing our
probes specifically to lipid raft and non-lipid raft domains in the
plasma membrane is further supported by previous studies, where
membrane fractionation experiments were used to show that the
addition of MyrPalm leads to co-localization in membrane
fractions where raft marker proteins are found, while attachment
of the CAAX sequence leads to exclusion from those membrane
fractions [31–34].
Using an approach similar to the present study, Depry et al.
[33] targeted the FRET-based A-kinase activity reporter (AKAR)
to different lipid raft and non-lipid raft membrane domains in
HEK293 cells. In this complementary study, they found evidence
that basal PKA activity associated with lipid rafts is greater than
that found in non-lipid rafts. This might seem to contradict our
present findings, which indicate that there is greater basal cAMP
activity associated with non-lipid raft domains. However, direct
comparison of results from the two studies is complicated by
differences in the actual biosensors used. Activity of the AKAR
probe can be affected by differences in cAMP levels, but because it
actually responds to phosphorylation, its activity is also affected by
differences in PKA expression levels, as well as differences in
phosphatase activity.
Membrane Domains and Compartmentation of Receptor
Mediated Responses
HEK293 cells express both bARs and EPRs. However,
membrane fractionation studies have demonstrated that bARs
are associated primarily with lipid raft fractions, while EPRs are
associated with non-lipid raft fractions [8]. Evidence for differ-
ences in the subcellular pattern of cAMP produced by bARs and
EPRs was not evident in our initial experiments (compare
figures 2 and 3), because cAMP produced following maximal
Figure 5. Effect of direct adenylyl cyclase (AC) inhibition on basal and b-adrenergic receptor (bAR) stimulated cAMP activity in
different microdomains. A–C, time course of changes in FRET response (DR/R0) in cells expressing Epac2-camps (Epac2), Epac2-CAAX (CAAX), and
Epac2-MyrPalm (MyrPalm) following exposure to the AC inhibitor MDL12330A (MDL; 100 mM). Subsequent treatment with isoproterenol (Iso; 30 nM)
plus IBMX (100 mM) was used to elicit a maximal FRET response. D, comparison of average changes in FRET responses (*p,0.001). F–G, time course of
changes in FRET response (DR/R0) in cells expressing Epac2-camps (Epac2), Epac2-CAAX (CAAX), and Epac2-MyrPalm (MyrPalm) following exposure to
the adenylyl cyclase inhibitor MDL12330A (MDL; 100 mM) after first stimulating cAMP production with the bAR agonist isoproterenol (Iso; 10 nM). H,
comparison of average changes in FRET responses to 10 nM Iso and Iso+100 mM MDL12330A (n = 4–11; *p,0.05).
doi:10.1371/journal.pone.0095835.g005
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receptor activation alone resulted in saturation of all three
biosensors used in the present study. This was demonstrated by
the fact that subsequent addition of the non-specific PDE inhibitor
IBMX did not cause any further increase in the FRET response
observed. However, cholesterol depletion did selectively alter
responses to bAR stimulation, without affecting PGE1 responses,
supporting the idea that these receptors are indeed found in
different membrane domains.
Cholesterol depletion also revealed evidence that raft and non-
raft microdomains of the plasma membrane contribute to
receptor-dependent compartmentation of cAMP production
(figure 4). Under these conditions, there was a significant
decrease in the size of the cAMP response occurring in lipid raft
domains, as detected by Epac2-MryPalm. In addition, there was a
significant decrease in the size of the response occurring
throughout the entire cell, as detected by Epac2-camps, which
supports the idea that most of this cAMP originated from bARs
found in lipid rafts. bAR stimulation did, however, produce a
significant increase in cAMP in non-lipid raft domains, as detected
by Epac2-CAAX. Yet this response was not significantly affected
by cholesterol depletion. This is consistent with the idea that at
least some fraction of the bARs in HEK293 cells are located in
non-raft regions of the plasma membrane [8].
Activation of EPRs, like bARs, produced responses that were
detected in the bulk cytoplasmic compartment, as well as
microdomains associated with lipid rafts and non-lipid rafts.
However, the observation that none of these responses were
affected by cholesterol depletion indicates that they were mediated
by receptors found primarily in non-lipid raft fractions of the
plasma membrane. This suggests that in HEK293 cells, cAMP
produced by EPRs may not be influenced by the same
mechanisms that restrict cAMP signaling by bARs found in non-
lipid raft domains. It is possible that not all non-raft domains are
identical, and the mechanisms for compartmentation may vary.
Alternatively, there may be significantly more EPRs in non-raft
domains, and the size of the cAMP response simply overwhelms
any mechanism for compartmentation.
The effect that cholesterol depletion has on GPCR responses is
quite mixed [42]. It has been reported to both facilitate and inhibit
many different receptor mediated responses. The exact explana-
tion for the apparent discrepancies is unclear. In some cases, the
variability may be a function of the specific type of receptor and/
or cell involved. Consistent with the present study, we previously
reported that cholesterol depletion altered bAR, but not EPR,
responses in cardiac myocytes [22]. However, in that study,
cholesterol depletion actually enhanced the response to bAR
stimulation. In cardiac myocytes, bAR stimulation of cAMP
production involves the regulation of AC5/6 activity in caveolae, a
specific subset of lipid rafts associated with the scaffolding protein
caveolin [56]. It has been hypothesized that cholesterol depletion
in cardiac cells disrupts an inhibitory interaction between caveolin
and AC, resulting in increased cAMP production [22,57].
However, not all HEK293 cells express endogenous caveolins
[57,58]. This might explain why cholesterol depletion did not
enhance bAR production of cAMP associated with lipid rafts in
the present study. The decrease in cAMP production may have
been due to disruption of receptor coupling with downstream
signaling elements [27].
Figure 6. Effect of direct adenylyl cyclase (AC) stimulation on cAMP activity in different microdomains. A–C, time course of changes in
normalized FRET response (DR/R0) in cells expressing Epac2-camps (Epac2), Epac2-CAAX (CAAX), and Epac2-MyrPalm (MyrPalm) following exposure
to a sub-maximally stimulating concentration of the AC activator forskolin (Fsk; 1 mM). Responses are normalized to the magnitude of the response
produced by subsequent exposure to a maximally stimulating concentration of Fsk (10 mM). D, comparison of average changes in normalized FRET
responses (n = 7–12; *p,0.001).
doi:10.1371/journal.pone.0095835.g006
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Membrane Domains and Compartmentation of Basal
cAMP
We also observed a difference in the magnitude of the FRET
response recorded in different subcellular locations following
receptor activation. The maximal response detected by Epac2-
camps and Epac2-MyrPalm was significantly greater than that
detected by Epac2-CAAX. Previous studies have suggested such
findings reflect cAMP compartmentation due to PDE activity [9].
However, exposure to the non-selective PDE inhibitor IBMX did
not alter any of the responses produced by maximal bAR or EPR
activation in the present study. Instead, we found evidence that the
difference in the magnitude of the maximal responses was due to
differences in the basal cAMP level in different subcellular
locations. Consistent with this conclusion, we found that inhibition
of basal AC activity with MDL12330A produced a significant
decrease in the FRET response of the Epac2-CAAX probe, but
not the other probes. This indicates that not only do membrane
microdomains contribute to differences in bAR signaling, but they
also are associated with differences in basal cAMP levels. Using the
approach previously described [43], we estimated the actual
concentrations of cAMP under basal conditions in the different
domains. Consistent with previous studies, we found that cAMP
levels tend to be higher near the plasma membrane than they are
throughout the rest of the cell [9–11,28,45,49]. However, in the
present study, we demonstrate there are significant differences
between the levels associated with lipid-raft and non-lipid raft
membrane domains.
The explanation for the difference in basal cAMP levels appears
to be due at least in part to differences in basal AC activity. This is
supported by the observation that cAMP responses in non-lipid
raft domains were more sensitive to direct activation of AC with
forskolin (see figure 6). It has been shown that different AC
isoforms may be targeted to specific membrane domains as
determined by membrane fractionation. In HEK293 cells, AC5/6
is concentrated in lipid rafts, while AC2, AC4, and AC9 are found
exclusively in non-lipid raft membrane fractions [16]. Further-
more, AC2 has been shown to exhibit a greater intrinsic basal
activity than AC5 or AC6 [59,60]. Differences in forskolin
sensitivity could also be explained by enhanced basal interactions
with the stimulatory G protein Gs as well as intrinsic GPCR
activity [61].
We also examined the possibility that differences in basal cAMP
activity might be explained by non-uniform distribution of PDEs.
Previous studies have focused on PDE4 activity as the predom-
inant isoform in HEK293 cells [10]. However, more recent studies
have found that approximately 30% of the PDE activity in HEK
Figure 7. Effect of phosphodiesterase (PDE) inhibition on cAMP activity in different microdomains. A and C, time course of changes in
normalized FRET response (DR/R0) recorded in cells expressing Epac2-camps (Epac2), Epac2-CAAX (CAAX), and Epac2-MyrPalm (MyrPalm) following
exposure to a sub-maximally stimulation concentration of isoproterenol (Iso; 1 nM) and subsequent addition of selective the selective PDE3 inhibitor
cilostamine (Cil) or the selective PDE4 inhibitor rolipram (Rol). Responses to PDE inhibition are normalized to the magnitude of the response
produced by 1 nM Iso alone. B, comparison of average changes in normalized FRET responses to 10 mM cilostamide (n = 8–13; ns = not significant).
D, comparison of average changes in normalized FRET responses to inhibition of PDE4 activity with rolipram 10 mM rolipram (n= 5–11; *p,0.05).
doi:10.1371/journal.pone.0095835.g007
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cells may be attributed to PDE3 [44,45]. We evaluated the
potential contribution of both isoforms using a pharmacologic
approach. Inhibition of either PDE3 or PDE4 activity alone had
no effect on basal cAMP activity detected by any of the probes. So
the only way we could evaluate the potential effect of PDE activity
in the different domains was following partial activation of AC
activity with Iso. In this case, inhibition of both isoforms had an
effect. However, the only significant difference we saw was a
slightly smaller effect of PDE4 inhibition on cAMP responses
detected by Epac2-CAAX in the non-lipid raft domain. This
suggests that non-uniform distribution of PDE4 activity might
conceivably contribute to the variations in basal cAMP activity
associated with different membrane domains. However, bAR
activation of protein kinase A may also upregulate PDE3 and
PDE4 activity through a positive feedback mechanism, which
might explain why inhibition of PDE activity had no detectible
effect under basal conditions.
Computational Analysis
Previous studies have provided evidence clearly demonstrating
that PDE activity contributes to differences between cAMP levels
near the membrane and those in the bulk cytosolic compartment
in HEK293 cells [9–12]. In fact, Oliveira et al. [14] used a
computational approach to conclude that PDE activity alone is
sufficient to explain cAMP compartmentation. However, PDE
activity was assumed to be exceptionally high in that study. The
authors found that compartmentalized behavior was lost when
PDE activity was reduced to a level that is still orders of magnitude
greater than estimates calculated using the experimental results of
Lynch et al. [44]. Based on those estimates, our model supports the
idea that PDE activity contributes to compartmentation, our
results also indicate that differences in total AC activity play a role.
However, the model clearly demonstrates that while these factors
are critical, they alone are not sufficient.
Our calculations indicate that compartmentation can only be
explained if the diffusion of cAMP between compartments is
limited. Without this, all compartmentalized behavior is lost. It is
difficult to estimate actual diffusion coefficients from the flux rates
used in our model, because this requires information about the size
and shape of the microdomains that is currently unknown. Using
assumptions similar to those of Rich et al. [11], it is clear that the
movement of cAMP throughout the cell must be significantly
slower than free diffusion. Our current results suggest, however,
that the average rate of cAMP diffusion between membrane
domains is slower than the rate of diffusion between either of the
membrane domains and the bulk cytoplasmic compartment. At
present, we are not able to reasonably model the PGE1 and Iso
data because both of those receptors produce saturating responses,
limiting our ability to define the cAMP concentrations they
produce.
Conclusions
The results of the present study demonstrate that cAMP
signaling near the plasma membrane is not homogeneous.
Compartmentation of bAR mediated cAMP responses appears
to correlate with the microdomain in which the receptors are
expressed. bARs associated with both lipid raft as well as non-lipid
raft domains stimulate cAMP production, but only those receptors
associated with lipid rafts appear to contribute to global cAMP
responses. bARs associated with non-lipid rafts appear to produce
more localized cAMP responses. There are also differences in
basal cAMP levels associated with lipid raft and non-raft
Figure 8. Comparison of computational and experimental results. A, basal cAMP concentration. B, response to a 20 fold increase in adenylyl
cyclase (AC) activity (model) and 1 mM forskolin (experiment) normalized to 300 fold increase in AC activity (model) and 10 mM forskolin (experiment).
C, response to a 90% reduction of PDE3 activity (model) and 10 mM cilostamide in the presence of 3 nM isoproterenol (experiment) normalized to
response to 3 fold increase in basal AC activity (model) and 3 nM isoproterenol (experiment). D, response to a 40% reduction of PDE4 activity (model)
and 10 mM rolipram in the presence of 3 nM isoproterenol (experiment) normalized to a 5 fold increase in basal AC activity (model) and 3 nM
isoproterenol (experiment).
doi:10.1371/journal.pone.0095835.g008
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microdomains. Differences in adenylyl cyclase and PDE activity
may contribute to some of these behaviors, but quantitative
modeling suggests that these factors alone are not sufficient.
Materials and Methods
Plasmid Construction
Plasmids were constructed using the pcDNA3.1 (Life Technol-
ogies) mammalian expression vector. The Epac2-camps FRET-
based cAMP biosensor was modified by site-directed mutagenesis
to add targeting sequences in order to record changes in cAMP
levels associated with specific membrane microdomains
(figure 1A). Epac2-MyrPalm was designed to report cAMP
changes in membrane raft domains. This plasmid contains an N-
terminal acylation sequence (GCINSKRKD) from Lyn kinase,
which results in myristoylation and palmitoylation that targets
proteins to lipid raft/caveolar membrane fractions [31]. Epac2-
CAAX was designed to report cAMP changes in non-raft
membrane microdomains. This plasmid contains the CAAX box
sequence (KKKKSKTKCVIM) from Rho GTPase attached to
carboxyl terminus of Epac2-camps (figure 1A), which results in
specific targeting of proteins to non-lipid raft domains of the
plasma membrane [31]. The DNA fragments encoding Epac2-
CAAX and Epac2-MyrPalm were amplified from pcDNA
constructs using Platinum PCR Supermix High Fidelity (Agilent
Technologies, CA). Amplified sequences were then directionally
cloned into pShuttle-CMV vector in MCS using HindIII(59) and
EcoRV(39) restriction sites. Adenovirus constructs of these
plasmids were generated using AdEasy XL adenoviral vector
system (Agilent Technologies, CA) following the manufacturer’s
protocol.
Cell Culture
Human embryonic kidney (HEK) 293 cells were maintained in
DMEM containing 10% fetal bovine serum as well as 100 units/
ml penicillin and 100 mg/ml streptomycin. For FRAP and FRET
experiments, cells were grown on 35 mm glass-bottom fluor-
odishes (World Precision Instruments, Inc.). Cells were transduced
with adenoviruses using a multiplicity of infection (MOI) of 1–10
for each virus. Cells were used 48–72 hours post transduction. All
experiments were conducted at room temperature unless other-
wise stated. In cholesterol depletion experiments, cells were
incubated in DMEM containing 5 mM methyl-b-cyclodextrin
(MBCD) for 1 hour at 37uC.
Imaging Experiments
All experiments were conducted using cells bathed in the
following solution (in mM): NaCl 137, KCl 5.4, MgCl2 0.5, CaCl2
1.0, NaH2PO4 0.33, glucose 5.5, and HEPES 5 (pH 7.4). FRET
imaging was conducted on the stage of an inverted microscope
(Olympus IX71) using an OrcaD2 dual chip CCD camera and
HCImage data acquisition and analysis software (Hamamatsu).
Changes in cAMP activity were defined as the change in
Table 1. Model parameters.
Parameter Initial Value Units Constraints Final Value Ref
Total cell volume 2.5 pL fixed 2.5 [11]
Vbulk Bulk cytoplasmic
compartment volume
2.375 pL fixed 2.375 [11]
Vlipid Lipid raft compartment
volume
0.0375 pL fixed 0.0375 [20]
Vnon-lipid Non-lipid raft compartment
volume
0.0875 pL fixed 0.0875 [20]
Total PDE activity 0.35 mM/s fixed 0.35 [44]
Total PDE3 activity 0.095 mM/s ,33% of Total PDE activity 0.095 [44]
PDE3non-lipid PDE3 Vmax in non-lipid rafts 0.075 mM/s ,50% of Total PDE3 activity 0.06 [45]
PDE3lipid PDE3 Vmax in lipid rafts 0.02 mM/s Total PDE3 activity - PDE3non-lipid 0.035 [45]
KmPDE3 PDE3 KM for cAMP 0.38 mM 0.18–0.38 0.38 [66]
Total PDE4 activity 0.255 mM/s Total PDE activity - Total PDE3 activity 0.255 [44]
PDE4non-lipid PDE4 Vmax in non-lipid rafts 0.028 mM/s Total PDE4 - PDE4bulk - PDE4lipid 0.055 [44,45]
PDE4lipid PDE4 Vmax in lipid rafts 0.027 mM/s Total PDE4 - PDE4bulk - PDE4non-lipid 0.01 [44,45]
PDE4bulk PDE4 Vmax in bulk cytoplasm 0.2 mM/s .50% of total PDE4 activity 0.19 [45]
KmPDE4 PDE4 KM for cAMP 1.2 mM 1.2–10 1.23 [66]
Total AC activity 0.05 mM/s fixed 0.05 [48]
AClipid AC activity in lipid rafts 0.0015 mM/s ,40% of Total AC activity 0.005
ACnon-lipid AC activity in non-lipid rafts 0.0485 mM/s Total AC activity - AClipid 0.045
flux1 Flux rate between
Vnon-lipid and Vbulk
2.90E-14 Liters/s model output 2.87E-14 [10,11]
flux2 Flux rate between
Vlipid and Vbulk
4.49E-14 Liters/s model output 4.45E-14 [10,11]
flux3 Flux rate between
Vnon-lipid and Vlipid
3.68E-15 Liters/s model output 1.47E-15 [10,11]
Adenylyl cyclase (AC) and phosphodiesterase (PDE) activities were estimated from published rates of cAMP production or hydrolysis (pmol/mg/min), respectively,
assuming HEK293 cell volume of 2.5 pL [11] and a protein concentration of 1.2 ng/cell (R. Ostrom, personal communication).
doi:10.1371/journal.pone.0095835.t001
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background and bleed-through corrected eCFP/eYFP fluores-
cence intensity ratio (DR) relative to the baseline ratio (R0)
measured throughout the entire cell as described previously
[22,30,62,63].
Confocal imaging was performed using an Olympus Fluoview
1000 confocal microscope. The expression pattern of the various
biosensors was determined using an argon laser (515 nm line) to
excite eYFP. Images were exported as tiff files, and the contrast and
brightness of these images were adjusted in ImageJ software for
presentation purposes. Fluorescence recovery after photobleaching
(FRAP) experiments were conducted using Olympus Diffusion
Measurement Package (DMP) software. The diameter of a 2.5 mM
circular region was aligned with the membrane along the edge of
the cell. This area was then bleached using the laser at full (100%)
power. Images were collected every 1.5 s before and after bleaching
using a laser intensity of 1–2% (figure S1). Fluorescence recovery
curves were generated by plotting recovery of relative fluorescence
in the bleached area as a function of time. The mobile fraction (Mf)
and fluorescence recovery half time (t1/2) were calculated as
described by DiBenedetto et al. [64], using the formula: Mf =
(F‘ – F0)/(Fi – F0) where F‘ is the fluorescence in the bleached area
at the end of the recovery period, F0 is fluorescence just after
photobleaching, and Fi is the fluorescence before bleaching. The t1/2
was calculated as the time required for the fluorescence intensity to
recover to 50% of F‘. All measurements were corrected for
background fluorescence and any photobleaching that may have
occurred during image acquisition.
Calibration of Biosensors
Lysates of HEK293 cells expressing each cAMP biosensor were
prepared following the method as described by Wachten et al. [28].
Briefly, cells were washed twice with ice-cold phosphate-buffered
saline and then centrifuged at 200 g for 5 minutes. The pellet was
resuspended in 5 mM Tris-HCl, 2 mM EDTA (pH 7.4) and lysed
by passaging through a 21-gauge needle. The lysate was then
centrifuged at 200,000 g for 20 minutes at 4uC. FRET measure-
ments were performed in 96 well plates using a Chameleon V
multitechnology plate reader (Hidex). Excitation of eCFP was
achieved using a 440/20 excitation filter. Emissions of eCFP and
eYFP were measured using 480/30 and 535/24 band-pass filters,
respectively. The cAMP concentrations producing half-maximal
responses (EC50) and the Hill coefficients (n) of the relationships
(figure S2) were determined by fitting the data to a three parameter
logistic equation using SigmPlot (Systat Software).
Calculation of Cellular cAMP Concentration
The concentrations of cAMP detected in situ were estimated
using the method according to Borner et al. [43], using the
equation:
½cAMP~EC50 R{Rmin
Rmax{R
 1
n
ð1Þ
where EC50 and n were determined as described above. We
previously demonstrated that these values are not significantly
affected when measured in vitro [30]. The same is not true for the
minimum and maximum FRET ratios (R), which must be measured
in the intact cell [43]. Therefore, Rminwas defined as the FRET ratio
observed in vivo following inhibition of basal adenylyl cyclase activity
with 100 mM MDL, and Rmax was defined as the FRET ratio
observed following exposure to agonist plus IBMX.
Materials
MDL 12330A, cilostamide, and rolipram were obtained from
Tocris. DMEM, penicillin/streptomycin, fetal bovine serum were
purchased from Life Technologies. All other reagents were
purchased from Sigma-Aldrich unless otherwise stated.
Computational Modeling
A quantitative model of cAMP signaling consisting of non-lipid
raft, lipid raft, and bulk cytosolic compartments was generated
using the following equations:
Non-lipid raft domain
Flux1~1e12  flux1  cAMPnon{lipid{cAMPbulk
Vnon{lipid
 
ð2Þ
Flux3~1e12  flux3  cAMPnon{lipid{cAMPlipid
Vnon{lipid
 
ð3Þ
dcAMPnon{lipid
dt
~ACnon{lipid{
PDE3non{lipidcAMPnon{lipid
KmPDE3zcAMPnon{lipid
z
PDE4non{lipidcAMPnon{lipid
KmPDE4zcAMPnon{lipid
 
{Flux1{Flux3
ð4Þ
Lipid-raft domain
Flux2~1e12  flux2  cAMPlipid{cAMPbulk
Vlipid
 
ð5Þ
Flux3~1e12  flux3  cAMPlipid{cAMPnon{lipid
Vlipid
 
ð6Þ
dcAMPlipid
dt
~AClipid{
PDE3lipid  cAMPlipid
KmPDE3zcAMPlipid
z
PDE4lipid  cAMPlipid
KmPDE4zcAMPlipid
 
{Flux2{Flux3
ð7Þ
Bulk cytosolic domain
Flux1~1e12  flux1  cAMPnon{lipid{cAMPbulk
Vbulk
 
ð8Þ
Flux2~1e12  flux2  cAMPlipid{cAMPbulk
Vbulk
 
ð9Þ
dcAMPbulk
dt
~Flux1zFlux2{
PDE4bulk  cAMPbulk
KmPDE4zcAMPbulk
 
ð10Þ
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Model Construction and Optimization
Definitions and initial values for model parameters were based
on experimental data as described in table 1. A modified Nelder
Mead Simplex constrained optimization method implemented in
C++ was used for simultaneous optimization of parameters to four
experimental protocols: basal cAMP concentrations in different
domains (figure 8A), effect of stimulating AC activity with
forskolin on FRET responses in different domains (figure 8B),
comparing effect of PDE3 inhibition on FRET responses in
different domains after stimulating AC activity (figure 8C), effect
of inhibiting PDE4 activity on FRET responses in different
domains after stimulating AC activity (figure 8D). The optimi-
zation determines the set of model parameters that can best
simulate the experimental results.
A cost function for each protocol was defined as the sum of
squared relative differences between experiment and simulation.
The total cost function (sum of the individual protocol errors)
was then minimized and converged with a tolerance of 1E-6.
During optimization, parameters were allowed to fluctuate
within the experimentally reported ranges as indicated in
table 1.
To simulate the forskolin experiments in figure 8, cAMP
concentrations were computed under (A) baseline conditions, (B)
following 20-fold increased AC activity, and (C) under maximal
stimulation (300-fold increase) of AC activity. Using the FRET
probe calibration curve, the cAMP concentrations were converted
to FRET response values. Finally, we calculated the relative size of
the response to partial AC stimulation as a fraction of the response
to maximal AC stimulation: (B-A)/(C-A).
For PDE3 and PDE4 inhibition simulations, the model was used
to calculate cAMP concentration under (A) baseline conditions, (B)
following 3-fold increased AC activity, and (C) following elimina-
tion of 90% PDE3 or 40% PDE4 activity. Again, using the FRET
probe calibration curve, the cAMP concentrations were converted
to FRET response values. Then, we determined the size of the
response to elimination of PDE activity relative to the size of the
response to partial AC stimulation: (C-A)/(B-A).
We undertook a sensitivity analysis [65] to determine how
changes to individual model parameters would affect cAMP
FRET probe responses in each of the three subcellular compart-
ments. In each case, the model parameters were increased and
decreased by 10%. The relative changes in the predicted responses
of each FRET probe were then used to calculate the sensitivity
according to the following equation:
ln
relative FRET probe response with paraeter at z10%
relative FRET probe response with paraeter at {10%
 
ln
parameter atz10%
parameter at{10%
  ð11Þ
Results of the sensitivity analysis are illustrated in figures S3–
S5.
Statistics
All data are expressed as the mean ? S.E.M of the indicated
number of independent experiments (n). Statistical significance
(P,0.05) was determined by Student’s t-test or one way ANOVA,
with Dunnett’s post-hoc analysis where appropriate.
Supporting Information
Figure S1 Effect of cholesterol depletion on the mobility of
the membrane bound biosensors Epac2-CAAX or Epac2-
MyrPalm was determined by conducting fluorescence recovery
after photobleaching (FRAP) experiments in control and
MBCD-treated HEK293 cells. The diameter (2.5 mm) of a
circular area was centered over a region of the cell membrane
(arrows) and bleached using the 515 nm line of an argon laser
at full power. The representative images illustrate the
fluorescence intensity before photobleaching (prebleach), im-
mediately after bleaching (bleach), and then 10 and 90 s into
the recovery phase.
(TIF)
Figure S2 In vitro concentration-response curves for cAMP
activation of FRET based biosensors (n=3–7). EC50: Epac2-
camps, 0.31 mM, Epac2-MyrPalm, 0.43 mM; Epac2-CAAX,
0.16 mM. Hill coefficient, Epac2-camps, 0.84; Epac2-MyrPalm,
0.82, Epac2-CAAX, 1.1. See Materials and Methods for details.
(TIF)
Figure S3 Sensitivity analysis of parameters used in simulating
responses to direct activation of adenylyl cyclase with forskolin.
See Materials and Methods for details.
(TIF)
Figure S4 Sensitivity analysis of parameters used in simulating
responses to inhibition of PDE3 activity with cilostamide. See
Materials and Methods for details.
(TIF)
Figure S5 Sensitivity analysis of parameters used in simulating
responses to inhibition of PDE4 activity with rolipram. See
Materials and Methods for details.
(TIF)
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